# Rewilding the Human Gut: Reintroduction of the Species Limosilactobacillus Reuteri

> **NCT03501082** · NA · COMPLETED · sponsor: **University of Alberta** · enrollment: 30 (actual)

## Conditions studied

- Microbial Colonization

## Interventions

- **OTHER:** L Reuteri PB-W1 Strain
- **OTHER:** L. Reuteri DSM20016T Strain
- **OTHER:** Placebo
- **OTHER:** Non-Industrialized-Type Diet

## Key facts

- **NCT ID:** NCT03501082
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-21
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03501082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03501082, "Rewilding the Human Gut: Reintroduction of the Species Limosilactobacillus Reuteri". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03501082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*